Literature DB >> 22968846

Lead vegetations in patients with local and systemic cardiac device infections: prevalence, risk factors, and therapeutic effects.

Pier Giorgio Golzio1, Anna Laura Fanelli, Melissa Vinci, Elisa Pelissero, Mara Morello, Walter Grosso Marra, Fiorenzo Gaita.   

Abstract

AIMS: Actual rates of lead vegetations (LVs) in cardiovascular device infections (CDI) are debated in this study. The aim of this study is to characterize prevalence and risk factors of LV in patients with CDI treated with lead extraction (LE). METHODS AND
RESULTS: Between 2003 and 2011, 293 leads were extracted from 136 patients (age 70.5 ± 14.5 years, 109 male) with infective indications: 39.2% chronic draining sinus, 20.9% pocket infections, and 28.8% systemic infections/sepsis. All patients underwent transesophageal echocardiography (TEE) before LE. Lead vegetation prevalence was 40.4%: 62.2% in systemic infection, but noteworthy in local infection/chronic draining sinus (21.9/36.4%). Younger age, renal disease, ad dialysis were associated with systemic infection. Fever after last intervention, revision, previous reparative procedure, infection at wound/device site and infection >6 months were associated with local infection/chronic draining sinus. Cardiac resynchronization therapy device, fever after last intervention, infection <6 months, renal disease, dialysis, abnormal chest X-ray, fever at admission, pulmonary symptoms, white blood cell (WBC) count, erythrocyte sedimentation rate, C-reactive protein increase and positive blood samples were related to LV. Risk of vegetations was reduced by antibiotic prophylaxis. Multivariate analysis indicated that renal failure and increased WBC count were related to LV.
CONCLUSION: Lead vegetations were frequently observed in patients with only local symptoms. Therefore, TEE should be mandatory in all patients undergoing LE for infective indications.

Entities:  

Mesh:

Year:  2012        PMID: 22968846     DOI: 10.1093/europace/eus240

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  10 in total

1.  Cardiac Implantable Electronic Device Infection in Patients at Risk.

Authors:  Khaldoun G Tarakji; Christopher R Ellis; Pascal Defaye; Charles Kennergren
Journal:  Arrhythm Electrophysiol Rev       Date:  2016-05

2.  Extraction of chronically implanted cardiovascular electronic device leads.

Authors:  Jeffrey Brinker
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-08

3.  Three dimensional transesophageal echocardiography: a missing link in infective endocarditis imaging?

Authors:  Domenico Galzerano; Abdulhalim J Kinsara; Sara Di Michele; Olga Vriz; Bahaa M Fadel; Rita Leonarda Musci; Maurizio Galderisi; Hani Al Sergani; Paolo Colonna
Journal:  Int J Cardiovasc Imaging       Date:  2020-01-04       Impact factor: 2.357

4.  Clinical manifestations of lead-dependent infective endocarditis: analysis of 414 cases.

Authors:  A Polewczyk; M Janion; R Podlaski; A Kutarski
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-05-03       Impact factor: 3.267

5.  Simultaneous lead extraction and vacuum-assisted vegetation removal.

Authors:  Ziad F Issa; Nilesh J Goswami
Journal:  HeartRhythm Case Rep       Date:  2015-08-21

6.  Three-dimensional Transesophageal Echocardiographic Diagnosis of Catheter Endocarditis Hidden in Intracaval Stent.

Authors:  Rita Leonarda Musci; Cataldo Girasoli; Fabrizio Fumarola; Carlo D'Agostino; Paolo Colonna
Journal:  J Cardiovasc Echogr       Date:  2018 Apr-Jun

7.  Clinical manifestations of device-related infective endocarditis in cardiac resynchronization therapy recipients.

Authors:  Ewa Jędrzejczyk-Patej; Michał Mazurek; Oskar Kowalski; Adam Sokal; Agnieszka Liberska; Mariola Szulik; Tomasz Podolecki; Zbigniew Kalarus; Radosław Lenarczyk
Journal:  Arch Med Sci       Date:  2018-08-07       Impact factor: 3.318

8.  Outcomes of Patients Hospitalized With Cardiovascular Implantable Electronic Device-Related Infective Endocarditis, Prosthetic Valve Endocarditis, and Native Valve Endocarditis: A Nationwide Study, 2003 to 2017.

Authors:  Pegah Khaloo; Uwajachukwumma A Uzomah; Ayman Shaqdan; Pablo A Ledesma; Jennifer Galvin; Leon M Ptaszek; Jeremy N Ruskin
Journal:  J Am Heart Assoc       Date:  2022-08-24       Impact factor: 6.106

9.  Influence of the type of pathogen on the clinical course of infectious complications related to cardiac implantable electronic devices.

Authors:  Anna Polewczyk; Wojciech Jacheć; Luca Segreti; Maria Grazia Bongiorni; Andrzej Kutarski
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

10.  Pacemaker Lead Endocarditis Investigated with Intracardiac Echocardiography: Factors Modulating the Size of Vegetations and Larger Vegetation Embolic Risk during Lead Extraction.

Authors:  Carlo Caiati; Paolo Pollice; Mario Erminio Lepera; Stefano Favale
Journal:  Antibiotics (Basel)       Date:  2019-11-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.